» Articles » PMID: 23804715

Role of IRF4 in IFN-stimulated Gene Induction and Maintenance of Kaposi Sarcoma-associated Herpesvirus Latency in Primary Effusion Lymphoma Cells

Overview
Journal J Immunol
Date 2013 Jun 28
PMID 23804715
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

IFN regulatory factor (IRF) 4 is a hematopoietic cell-specific transcription factor that regulates the maturation and differentiation of immune cells. Using an inducible expression system, we found that IRF4 directly induced a specific subset of IFN-stimulated genes (ISGs) in a type I IFN-independent manner in both epithelial and B cell lines. Moreover, Kaposi sarcoma-associated herpesvirus (KSHV)-encoded viral FLICE inhibitory protein (vFLIP) enhances IRF4-mediated gene induction. Coexpression of IRF4 with vFLIP significantly increased ISG60 (IFIT3) and Cig5 (RSAD2) transcription that was dependent on the ability of vFLIP to activate NF-κB. A vFLIP mutant (A57L) defective in NF-κB activation failed to enhance IRF4-mediated ISG induction. Thus, we provide a physiologically relevant mechanism by which viral protein-mediated NF-κB activation modulates specific ISG induction by IRF4. In contrast, IRF4 also acted as a negative regulator of KSHV replication and transcription activator expression after induction of KSHV lytic reactivation in KSHV-positive primary effusion lymphoma cells. Taken together, these results suggest a dual role for IRF4 in regulating ISG induction and KSHV lytic reactivation in primary effusion lymphoma cells.

Citing Articles

IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications.

Wu R, Yang H, Liu C Front Immunol. 2025; 16:1515718.

PMID: 40061935 PMC: 11885914. DOI: 10.3389/fimmu.2025.1515718.


H3K27 demethylase KDM6B aggravates ischemic brain injury through demethylation of IRF4 and Notch2-dependent SOX9 activation.

Chang L, An Z, Zhang J, Zhou F, Wang D, Liu J Mol Ther Nucleic Acids. 2021; 24:622-633.

PMID: 33981480 PMC: 8076647. DOI: 10.1016/j.omtn.2021.01.021.


The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis.

Charostad J, Nakhaie M, Dehghani A, Faghihloo E Infect Agent Cancer. 2020; 15:62.

PMID: 33072180 PMC: 7559203. DOI: 10.1186/s13027-020-00317-4.


IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Rodriguez-Carrio J, Lopez P, Alperi-Lopez M, Caminal-Montero L, Ballina-Garcia F, Suarez A Front Immunol. 2019; 9:3085.

PMID: 30666255 PMC: 6330328. DOI: 10.3389/fimmu.2018.03085.


Persistent Replication of HIV, Hepatitis C Virus (HCV), and HBV Results in Distinct Gene Expression Profiles by Human NK Cells.

Boeijen L, Hou J, de Groen R, Verbon A, Boonstra A J Virol. 2018; 93(9).

PMID: 30185599 PMC: 6475777. DOI: 10.1128/JVI.00575-18.


References
1.
Honda K, Taniguchi T . IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006; 6(9):644-58. DOI: 10.1038/nri1900. View

2.
de Veer M, Sim H, Whisstock J, Devenish R, Ralph S . IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. Genomics. 1998; 54(2):267-77. DOI: 10.1006/geno.1998.5555. View

3.
Shair K, Schnegg C, Raab-Traub N . EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res. 2008; 68(17):6997-7005. PMC: 2593097. DOI: 10.1158/0008-5472.CAN-08-1178. View

4.
Lubyova B, Pitha P . Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol. 2000; 74(17):8194-201. PMC: 112355. DOI: 10.1128/jvi.74.17.8194-8201.2000. View

5.
Chaudhary P, Jasmin A, Eby M, Hood L . Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene. 1999; 18(42):5738-46. DOI: 10.1038/sj.onc.1202976. View